At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CR crane
Post-Mkt 08-17 16:15:57 EDT
218.59
+0.25
+0.11%
盘后218.59
+0.000.00%
16:10 EDT
High219.18Low211.22Vol432.74K
Open216.86D1 Closing218.34Amplitude3.65%
Mkt Cap12.59BTradable Cap10.66BTotal Shares57.60M
T/O94.34MT/O Rate0.89%Tradable Shares48.76M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

UroGen Submits NDA for UGN-103, an Investigational Treatment of Recurrent LG-IR-NMIBC
GlobeNewswire  ·  08-17 20:00
UroGen Submits NDA for UGN-103, an Investigational Treatment of Recurrent LG-IR-NMIBC
Crane Director James L. L. Tullis Sells 614 Shares for $138,150
Reuters  ·  08-15 04:51
Crane Director James L. L. Tullis Sells 614 Shares for $138,150
Press Release: Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
Dow Jones  ·  08-15 04:30
Press Release: Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
Press Release: Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
Dow Jones  ·  08-15 04:30
Press Release: Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
Moleculin Biotech Reports Second Quarter 2026 Financial Results and Highlights Continued Advancement of Pivotal MIRACLE Trial
GlobeNewswire  ·  08-14
Moleculin Biotech Reports Second Quarter 2026 Financial Results and Highlights Continued Advancement of Pivotal MIRACLE Trial
Press Release: Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update
Dow Jones  ·  08-14
Press Release: Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update
What Crane (CR)'s Acquisition-Fueled Guidance Hike Means For Shareholders
Simply Wall St.  ·  08-10
What Crane (CR)'s Acquisition-Fueled Guidance Hike Means For Shareholders
UroGen Reports $50.4 Million of ZUSDURI Revenue and Provides Second Quarter 2026 Financial Results and Highlights
GlobeNewswire  ·  08-05
UroGen Reports $50.4 Million of ZUSDURI Revenue and Provides Second Quarter 2026 Financial Results and Highlights
Moleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients
GlobeNewswire  ·  07-31
Moleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients
Crane is Maintained at Buy by DA Davidson
Dow Jones  ·  07-31
Crane is Maintained at Buy by DA Davidson
Analysts Offer Insights on Industrial Goods Companies: Crane Company (CR) and Madison Air Solutions Corp. Class A (MAIR)
TIPRANKS  ·  07-30
Analysts Offer Insights on Industrial Goods Companies: Crane Company (CR) and Madison Air Solutions Corp. Class A (MAIR)
Crane Co : D.a. Davidson Raises Target Price to $245 from $235
THOMSON REUTERS  ·  07-30
Crane Co : D.a. Davidson Raises Target Price to $245 from $235
Myers Industries Q2 Revenue Rises on Infrastructure and Food & Beverage Strength
Reuters  ·  07-30
Myers Industries Q2 Revenue Rises on Infrastructure and Food & Beverage Strength
Equipment Maker Terex Q2 Sales Beat Estimates, Lifts FY Outlook
Reuters  ·  07-30
Equipment Maker Terex Q2 Sales Beat Estimates, Lifts FY Outlook
Columbus McKinnon Q1 Sales Beat on Kito Crosby Acquisition Boost
Reuters  ·  07-30
Columbus McKinnon Q1 Sales Beat on Kito Crosby Acquisition Boost
Preformed Line Products Q2 Revenue Jumps 25% to Record High on Energy Demand
Reuters  ·  07-30
Preformed Line Products Q2 Revenue Jumps 25% to Record High on Energy Demand
DMC Global Q2 Sales Beat Estimates as Arcadia Results Improve
Reuters  ·  07-30
DMC Global Q2 Sales Beat Estimates as Arcadia Results Improve
Sturm Ruger Q2 Net Sales Rise on Strong Demand
Reuters  ·  07-30
Sturm Ruger Q2 Net Sales Rise on Strong Demand
Crane Co Reports Results for the Quarter Ended June 30 - Earnings Summary
Reuters  ·  07-29
Crane Co Reports Results for the Quarter Ended June 30 - Earnings Summary
GUIDANCE: (CR) Crane Expects Full Year 2026 Adjusted EPS Range $6.85 - $7.05, vs. FactSet Est of $6.85
MT Newswires Live  ·  07-29
GUIDANCE: (CR) Crane Expects Full Year 2026 Adjusted EPS Range $6.85 - $7.05, vs. FactSet Est of $6.85

Introduction

Company Name.
crane
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Crane NXT, Co. focuses on payment and merchandising technologies. It indents to offer electronic equipment and associated software leveraging extensive, and proprietary core capabilities, including payment verification and authentication, as well as automation solutions, field service solutions, remote diagnostics, and productivity enhancing software solutions. The company is based in Stamford, Connecticut.
Issue price:
--